AHA GUIDELINES Bundle (free trial)

Atrial Fibrillation 2023 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/387790

Contents of this Issue

Navigation

Page 95 of 131

96 Management Table 23. Specific Drug Therapy for Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation Drug Loading Dose Maintenance Dose Primary Route(s) of Elimination Dronedarone N/A 400 mg twice daily Liver metabolism Flecainide N/A 50–300 mg/d PO divided q 8–12 h Liver (70%) Kidney (30%) ¶ (cont'd)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Atrial Fibrillation 2023 Update